Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.111 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.111 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.1.15EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.1.1.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.15ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.1.1.15ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.1.1.15EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.1.1.15EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.1.1.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.1.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.16EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.7.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.16ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.7.16ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.7.16EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.7.16EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.7.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.3.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.3.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.3.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.3.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.3.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CQ.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CQ.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CQ.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CQ.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CQ.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CQ.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CQ.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CQ.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EC.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
EC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EC.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
EC.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EC.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EC.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EC.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.4.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.4.1.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.4.1.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.4.1.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.4.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used